CVE:VPT VentriPoint Diagnostics (VPT) Stock Price, News & Analysis C$0.20 -0.02 (-9.09%) (As of 07/26/2024 05:27 PM ET) Add Compare Share Share Today's RangeC$0.20▼C$0.2250-Day RangeC$0.20▼C$0.2452-Week RangeC$0.14▼C$0.36Volume104,000 shsAverage Volume97,875 shsMarket CapitalizationC$31.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Get VentriPoint Diagnostics alerts: Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About VentriPoint Diagnostics Stock (CVE:VPT)Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.Read More VPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VPT Stock News HeadlinesMay 24, 2024 | theglobeandmail.comClosing Bell: Ventripoint Diagnostics Ltd up on Thursday (VPT)May 6, 2024 | finance.yahoo.comVentripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug AdministrationJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 6, 2024 | msn.comWill Shares Rise on Milestone Development for AI-Powered Heart Technology?May 6, 2024 | bbc.co.ukApproval for new NHS diagnostic centre in MansfieldMay 2, 2024 | finance.yahoo.comVentripoint Diagnostics Full Year 2023 Earnings: CA$0.031 loss per share (vs CA$0.031 loss in FY 2022)April 14, 2024 | morningstar.comVentriPoint Diagnostics Ltd VPTMarch 28, 2024 | finance.yahoo.comVentripoint Diagnostics Provides Corporate Update and Announces Conference CallJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.March 4, 2024 | stockhouse.comEnhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to UseFebruary 21, 2024 | benzinga.comVentriPoint Diagnostics Stock (OTC:VPTDF) Dividends: History, Yield and DatesFebruary 14, 2024 | morningstar.comVentriPoint Diagnostics Ltd VPTDFFebruary 13, 2024 | stockhouse.comVentripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global SalesFebruary 1, 2024 | es-us.finanzas.yahoo.comThe Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging SystemJanuary 29, 2024 | finance.yahoo.comThe 2023 Year in ReviewDecember 12, 2023 | theglobeandmail.comHealthcare Stock Rallies Strongly Following Key ImplementationDecember 5, 2023 | finance.yahoo.comOllie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's HospitalsNovember 5, 2023 | morningstar.comAccelerate Diagnostics Inc AXDXSee More Headlines Receive VPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolCVE:VPT CUSIPN/A CIKN/A Webwww.ventripoint.com Phone416-848-4156FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,870,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-205.43% Return on Assets-78.41% Debt Debt-to-Equity Ratio217.41 Current Ratio1.17 Quick Ratio6.67 Sales & Book Value Annual SalesC$24,600.00 Price / Sales1,306.83 Cash FlowC$0.04 per share Price / Cash Flow5.53 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares156,820,000Free FloatN/AMarket CapC$32.15 million OptionableNot Optionable Beta0.43 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. George Adams B.A.Sc. (Age 76)ICD.D., M.A.Sc., Ph.D., Executive Chairman & Corporate Secretary Comp: $286kMr. Hugh MacNaughtInterim CEO, President & DirectorMr. Jimmy JeonChief Financial OfficerMr. Hirotaka KatagiriCTO & Business Development Division DirectorMr. Jim GrabaApplication Specialist & Chief TrainerKey CompetitorsProtech Home MedicalCVE:PTQProtech Home MedicalCVE:PHMHelius Medical TechnologiesTSE:HSMTheralase TechnologiesCVE:TLTAurora SpineCVE:ASGView All CompetitorsInsidersHugh MacnaughtBought 20,000 shares on 5/2/2024Total: C$4,420.00 ($0.22/share)Robert HodgkinsonBought 4,500 shares on 4/26/2024Total: C$945.00 ($0.21/share)Robert HodgkinsonBought 21,000 shares on 4/24/2024Total: C$4,410.00 ($0.21/share)Robert HodgkinsonBought 75,000 shares on 4/22/2024Total: C$15,900.00 ($0.21/share)Robert HodgkinsonBought 36,500 shares on 4/18/2024Total: C$7,774.50 ($0.21/share)View All Insider Transactions VPT Stock Analysis - Frequently Asked Questions How have VPT shares performed this year? VentriPoint Diagnostics' stock was trading at C$0.30 at the beginning of 2024. Since then, VPT stock has decreased by 32.2% and is now trading at C$0.20. View the best growth stocks for 2024 here. How do I buy shares of VentriPoint Diagnostics? Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of VentriPoint Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that VentriPoint Diagnostics investors own include Resverlogix (RVX), AuRico Gold Inc. Ordinary Share (AUQ), Kootenay Silver (KTN), ProMetic Life Sciences (PLI), Shopify (SHOP), Shockwave Medical (SWAV) and Barkerville Gold Mines Ltd. (BGM.V) (BGM). This page (CVE:VPT) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VentriPoint Diagnostics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share VentriPoint Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.